These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6974272)

  • 1. [The significance of lymphocytic infiltration in urologic tumors: studies of distributions of B and T-lymphocytes and its subsets, and functional analysis of the infiltrating lymphocytes (author's transl)].
    Akaza H
    Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):86-97. PubMed ID: 6974272
    [No Abstract]   [Full Text] [Related]  

  • 2. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors.
    Mostofi FK; Sesterhenn I
    Natl Cancer Inst Monogr; 1978 Dec; (49):133-41. PubMed ID: 571042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic aspects in urologic tumors].
    Ackermann R
    Med Klin; 1980 Jun; 75(12):436-41. PubMed ID: 6156392
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunocompetence and immunotherapy of patients with cancer of the kidney and bladder].
    Mokhort VA; Grigorovich NA; Strotskiĭ AV; Mavrichev AS
    Urol Nefrol (Mosk); 1986; (1):66-74. PubMed ID: 3513423
    [No Abstract]   [Full Text] [Related]  

  • 6. [Normal human lymphocyte mediated cytotoxicity against an established cell line (KU-2) derived from human renal cell carcinoma: role to T & B cells as effector (author's transl)].
    Jistukawa S
    Nihon Hinyokika Gakkai Zasshi; 1978 Dec; 69(12):1623-38. PubMed ID: 311392
    [No Abstract]   [Full Text] [Related]  

  • 7. [T and B lymphocytes in tumours of the urinary bladder (author's transl)].
    Fábryová V; Hornák M
    Bratisl Lek Listy; 1978 Mar; 69(3):292-9. PubMed ID: 305273
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte subsets in urologic cancer patients.
    Shaw M; Ray P; Rubenstein M; Guinan P
    Urol Res; 1987; 15(3):181-5. PubMed ID: 2957843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the cellular immune response in patients with upper urinary tract carcinoma compared with those in patients with bladder carcinoma and its postoperative change (author's transl)].
    Sakai S
    Nihon Hinyokika Gakkai Zasshi; 1980 Jun; 71(6):527-43. PubMed ID: 7431708
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
    Marten-Perolino R; Cocimano V; Botto A; Buffa G; Riggi E; Trapani C
    J Exp Pathol; 1987; 3(4):587-92. PubMed ID: 3454806
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract.
    Frick J; Aulitzky W; Fuchs D; Hausen A; Joos H; Reibnegger G; Wachter H
    Urol Int; 1985; 40(3):155-9. PubMed ID: 3874460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
    Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. III. Further functional investigations using cultured autochthonous tumor cell lines and freeze-thawed infiltrating inflammatory cells.
    Tötterman TH; Parthenais E; Häyry P; Timonen T; Saksela E
    Cell Immunol; 1980 Sep; 55(1):219-26. PubMed ID: 7191785
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tests for T- and B-lymphocytes in patients with silicosis (author's transl)].
    Gáliková E
    Cas Lek Cesk; 1982 May; 121(19):586-9. PubMed ID: 6980054
    [No Abstract]   [Full Text] [Related]  

  • 15. MHC-dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomas.
    Housseau F; Zeliszewski D; Roy M; Paradis V; Richon S; Ricour A; Bougaran J; Prapotnich D; Vallancien G; Benoit G; Desportes L; Bedossa P; Hercend T; Bidart JM; Bellet D
    Int J Cancer; 1997 May; 71(4):585-94. PubMed ID: 9178812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological evaluation in patients with urological cancers.
    Martinez-Piñeiro JA; Muntanola P; Hidalgo L
    Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface markers of lymphocytes infiltrating seminoma tissue.
    Akaza H; Kobayashi K; Umeda T; Niijima T
    J Urol; 1980 Dec; 124(6):827-8. PubMed ID: 6969322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double urologic tumors: reduced immunocompetence?].
    Klippel KF; Hutschenreiter G; Jacobi G; Graff J
    Onkologie; 1979 Feb; 2(1):12-6. PubMed ID: 392364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-associated macroglobulin in patients with seminoma testis: the influence of serum PAM on in vitro T-cell assays.
    Ferguson T; Crichton D; Duncan W
    Clin Oncol; 1979 Jun; 5(2):99-107. PubMed ID: 380863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.